Transgenomic (Omaha, NE) has introduced the SURVEY-OR Scan K-RAS kit, a mutation detection kit that features the SURVEYOR Nuclease and WAVE® HS DHPLC platform. It uses PCR amplification reaction and hybridization to form heteroduplex DNA molecules in samples with K-RAS mutation. K-RAS mutation status is a strong predictor of resitstance to cancer treatment. The kit detects mutations by enzymatic cleavage at mutation sites, and identifies all known and unknown mutations in both K-RAS coding exons. It also includes control templates for common mutation sites (codons 12, 13, and 61), and offers high analytic sensitivity, detecting 1% of K-RAS mutant in a background of wild-type genomic DNA. It can be applied to formalin-fixed paraffin-embedded tissues.

For Free Info Click Here 


Medical Design Briefs Magazine

This article first appeared in the March, 2010 issue of Medical Design Briefs Magazine.

Read more articles from this issue here.

Read more articles from the archives here.

Topics:
Imaging